Skip to main content

Lupin gets 2 observations from USFDA for Nagpur facility

Drug firm Lupin on Saturday said it has received two observations from the US health regulator following the inspection of its Nagpur manufacturing f

from Business Line - Companies https://ift.tt/309eDpi

Comments

Popular posts from this blog